MAY 19, 2020 3:32 PM PDT

COVID-19 Vaccine On Track for Late 2020

WRITTEN BY: Annie Lennon

Moderna, a biotechnology company based in Massachusetts, has released information on its vaccine against COVID-19 from its Phase I human trial conducted in March. One of eight vaccines globally that has begun human testing, the company’s chief medical officer says that it may be available for widespread use by late 2020 or early 2021. 

In an announcement, the company stated that from tests involving eight people, their vaccine appears to be safe and able to stimulate the production of antibodies against the COVID-19. Of those studies, each participant was healthy and aged between 18 and 55. The researchers found that antibodies present in the participants after receiving the vaccine were able to stop the virus from replicating under lab conditions. 

During the trial, participants were given three doses of the vaccine: low, medium and high. Side effects for those on low and medium doses were limited to redness and soreness where the vaccine was given. Meanwhile, for those on higher doses, three patients had a fever, muscle pains and headaches lasting no more than a day.

Due to the trial’s small sample size as well as its nature (only testing antibodies in lab conditions as opposed to real-life situations), rather than proving that the vaccine can trigger immunity against COVID-19, the data simply suggests that it may be effective. Further experimentation is needed to confirm this. To this end, Phase II trials involving 600 volunteers are expected to begin soon, followed by a third phase involving thousands of people in July. 

Nevertheless, Moderna’s Phase I testing is still underway- this time for two other age groups: those aged between 55 and 71 and over 71. The company has not mentioned any plans to include children in its studies. This is not surprising however as it is generally uncommon practice to test vaccines on children until safety among young adults has been established. 

Although the vaccine’s effectiveness in humans against the virus is still unknown, Moderna says that additional tests on vaccinated mice have shown that it is able to prevent the virus from spreading in their lungs. The company also said that the vaccine seemed to stimulate high levels of neutralizing antibodies in mice comparable to those in people having received the same vaccine. 

 

Sources: LabRoots, NYTimes, Washington Post

 

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
MAY 02, 2022
Cell & Molecular Biology
Pipette Matchmaker: Tip Compatibility Like Never Before
MAY 02, 2022
Pipette Matchmaker: Tip Compatibility Like Never Before
Article Written by John Winsor All lab workers have to do it, shifting countless stacks of indiscernible boxes to f ...
APR 22, 2022
Health & Medicine
Differences in the Impact of Acute and Chronic Cannabis Use on Stress Response Regulation
APR 22, 2022
Differences in the Impact of Acute and Chronic Cannabis Use on Stress Response Regulation
A new study published in Frontiers examined the influence of acute and chronic cannabis use on stress regulation. Althou ...
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
MAY 26, 2022
Cannabis Sciences
Cannabis Crystal Polymorphism
MAY 26, 2022
Cannabis Crystal Polymorphism
A new published commentary in the Journal of Cannabis Research indicated that cannabis crystallinity may determine level ...
JUN 06, 2022
Cannabis Sciences
Price and Convenience: Key Reasons Why People Continue to Buy Illegal Cannabis
JUN 06, 2022
Price and Convenience: Key Reasons Why People Continue to Buy Illegal Cannabis
A study published in the Journal of Studies on Alcohol and Drugs found that price and convenience are the two main reaso ...
JUL 01, 2022
Cannabis Sciences
Firefly Genes Provide Insights into Cannabis Biology
JUL 01, 2022
Firefly Genes Provide Insights into Cannabis Biology
A team of University of Connecticut researchers are using firefly genes to understand molecular mechanisms involved in t ...
Loading Comments...